Funamizu, N.; Mori, S.; Sakamoto, A.; Iwata, M.; Shine, M.; Ito, C.; Uraoka, M.; Ueno, Y.; Tamura, K.; Umeda, Y.;
et al. C-Reactive Protein-to-Albumin Ratio as a Predictive Indicator for Evaluating Tolerability in S-1 Adjuvant Chemotherapy after Curative Surgery for Pancreatic Cancer: An External Validation Cohort Study. Cancers 2024, 16, 3372.
https://doi.org/10.3390/cancers16193372
AMA Style
Funamizu N, Mori S, Sakamoto A, Iwata M, Shine M, Ito C, Uraoka M, Ueno Y, Tamura K, Umeda Y,
et al. C-Reactive Protein-to-Albumin Ratio as a Predictive Indicator for Evaluating Tolerability in S-1 Adjuvant Chemotherapy after Curative Surgery for Pancreatic Cancer: An External Validation Cohort Study. Cancers. 2024; 16(19):3372.
https://doi.org/10.3390/cancers16193372
Chicago/Turabian Style
Funamizu, Naotake, Shozo Mori, Akimasa Sakamoto, Miku Iwata, Mikiya Shine, Chihiro Ito, Mio Uraoka, Yoshitomo Ueno, Kei Tamura, Yuzo Umeda,
and et al. 2024. "C-Reactive Protein-to-Albumin Ratio as a Predictive Indicator for Evaluating Tolerability in S-1 Adjuvant Chemotherapy after Curative Surgery for Pancreatic Cancer: An External Validation Cohort Study" Cancers 16, no. 19: 3372.
https://doi.org/10.3390/cancers16193372
APA Style
Funamizu, N., Mori, S., Sakamoto, A., Iwata, M., Shine, M., Ito, C., Uraoka, M., Ueno, Y., Tamura, K., Umeda, Y., Aoki, T., & Takada, Y.
(2024). C-Reactive Protein-to-Albumin Ratio as a Predictive Indicator for Evaluating Tolerability in S-1 Adjuvant Chemotherapy after Curative Surgery for Pancreatic Cancer: An External Validation Cohort Study. Cancers, 16(19), 3372.
https://doi.org/10.3390/cancers16193372
